{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:07:28Z","timestamp":1792822048569,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":629,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1116876"],"award-info":[{"award-number":["1116876"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1173791"],"award-info":[{"award-number":["1173791"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000926","name":"Leukaemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003463","name":"Haematology Society of Australia and New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jtct.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:42:00Z","timestamp":1623073320000},"page":"798.e1-798.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report"],"prefix":"10.1016","volume":"27","author":[{"given":"Julian","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kerridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C.-A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.M.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Pergam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.05.028_bib0001","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0002","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","article-title":"Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?","volume":"29","author":"Horan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0003","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2021.05.028_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0006","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0007","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0008","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.bbmt.2017.08.010","article-title":"A new clinicobiological scoring system for the prediction of infection-related mortality and survival after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Forcina","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0009","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.bbmt.2015.05.019","article-title":"Establishment of definitions and review process for consistent adjudication of cause-specific mortality after allogeneic unrelated-donor hematopoietic cell transplantation","volume":"21","author":"Hahn","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1083-8791(00)70002-4","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"6","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0011","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.05.028_bib0012","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0013","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/TP.0b013e3181ec29f0","article-title":"WHO guiding principles on human cell, tissue and organ transplantation","volume":"90","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.05.028_bib0014","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41409-019-0718-7","volume":"55","author":"Snowden","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1705653","article-title":"Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation","volume":"39","author":"Hakki","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0016","first-page":"19:12762","article-title":"Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: three major threats to hematopoietic stem cell transplant recipients","author":"Satlin","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2021.05.028_bib0017","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtct.2020.10.001","article-title":"American Society of Transplantation and Cellular Therapy series, 1: Enterobacterales infection prevention and management after hematopoietic cell transplantation","volume":"27","author":"Satlin","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.05.028_bib0018","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2021.05.028_bib0019","doi-asserted-by":"crossref","first-page":"ofaa246","DOI":"10.1093\/ofid\/ofaa246","article-title":"Optimal treatment duration of Pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients","volume":"7","author":"Olearo","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2021.05.028_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41579-020-0327-x","article-title":"Innovative and rapid antimicrobial susceptibility testing systems","volume":"18","author":"van Belkum","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","article-title":"Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee","volume":"41","author":"Slavin","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.jtct.2021.05.028_bib0022","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1200\/JCO.18.01474","article-title":"Better sepsis management rather than fluoroquinolone prophylaxis for patients with cancer-related immunosuppression","volume":"37","author":"Slavin","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1060028019890886","article-title":"Inpatient antibiotic stewardship interventions in the adult oncology and hematopoietic stem cell transplant population: a review of the literature","volume":"54","author":"Pillinger","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtct.2021.05.028_bib0024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jinf.2018.02.014","article-title":"10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients","volume":"77","author":"MacAllister","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jtct.2021.05.028_bib0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imj.14462","article-title":"New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation","volume":"50","author":"Yong","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.jtct.2021.05.028_bib0026","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.bbmt.2020.07.002","article-title":"Letermovir prophylaxis decreases burden of cytomegalovirus (CMV) in patients at high risk for CMV disease following hematopoietic cell transplant","volume":"26","author":"Johnsrud","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0027","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41409-020-01082-z","article-title":"Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data","volume":"56","author":"Mori","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0028","doi-asserted-by":"crossref","first-page":"e13187","DOI":"10.1111\/tid.13187","article-title":"Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: real-world experience","volume":"21","author":"Lin","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2021.05.028_bib0029","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtct.2020.10.003","article-title":"American Society of Transplantation and Cellular Therapy series, 2: Management and prevention of aspergillosis in hematopoietic cell transplantation recipients","volume":"27","author":"Dadwal","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.05.028_bib0030","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jtct.2021.05.028_bib0031","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13693786.2011.587211","article-title":"Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors","volume":"50","author":"Zirkel","year":"2012","journal-title":"Med Mycol"},{"issue":"suppl 7","key":"10.1016\/j.jtct.2021.05.028_bib0032","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jtct.2021.05.028_bib0033","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/imj.12594","article-title":"Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand","volume":"44","author":"van Hal","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jtct.2021.05.028_bib0034","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcyt.2017.07.012","article-title":"Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant","volume":"19","author":"Sutrave","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2021.05.028_bib0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczy\u0144ski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.05.028_bib0036","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.bbmt.2020.06.030","article-title":"Unrelated donor transplant recipients given thymoglobuline have superior GRFS when compared to matched related donor recipients undergoing transplantation without ATG","volume":"26","author":"Othman","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0037","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12400","article-title":"The current role of T cell depletion in paediatric stem cell transplantation","volume":"162","author":"Booth","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.028_bib0038","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bmt.2008.150","article-title":"EBV reactivation and posttransplant lymphoproliferative disorders following allogeneic SCT","volume":"42","author":"Ocheni","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0039","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cid\/cit391","volume":"57","author":"Styczy\u0144ski","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2021.05.028_bib0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/pbc.20604","article-title":"The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?","volume":"47","author":"Greenfield","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2021.05.028_bib0041","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705289","article-title":"Preemptive diagnosis and treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development","volume":"37","author":"Weinstock","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0042","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bmt.1705550","article-title":"Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation","volume":"39","author":"Miano","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0043","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bmt.2010.177","article-title":"Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution","volume":"46","author":"Martino","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0044","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbmt.2009.02.007","article-title":"Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences","volume":"15","author":"Sorror","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.028_bib0045","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:51Z","timestamp":1763002911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721009477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2666636721009477"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.05.028","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}